Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Regenerative Medical Technology (RMTG) Gross Profit (2018 - 2025)

Historic Gross Profit for Regenerative Medical Technology (RMTG) over the last 8 years, with Q3 2025 value amounting to $501557.0.

  • Regenerative Medical Technology's Gross Profit fell 3286.26% to $501557.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 million, marking a year-over-year increase of 3221.6%. This contributed to the annual value of $2.8 million for FY2024, which is 6847.72% up from last year.
  • Latest data reveals that Regenerative Medical Technology reported Gross Profit of $501557.0 as of Q3 2025, which was down 3286.26% from $585832.0 recorded in Q2 2025.
  • Over the past 5 years, Regenerative Medical Technology's Gross Profit peaked at $980183.0 during Q4 2024, and registered a low of -$10347.0 during Q1 2021.
  • Over the past 5 years, Regenerative Medical Technology's median Gross Profit value was $434750.0 (recorded in 2023), while the average stood at $397746.0.
  • The largest annual percentage gain for Regenerative Medical Technology's Gross Profit in the last 5 years was 4340706.52% (2021), contrasted with its biggest fall of 119499.37% (2021).
  • Quarter analysis of 5 years shows Regenerative Medical Technology's Gross Profit stood at $80053.0 in 2021, then soared by 348.22% to $358814.0 in 2022, then grew by 21.16% to $434750.0 in 2023, then surged by 125.46% to $980183.0 in 2024, then plummeted by 48.83% to $501557.0 in 2025.
  • Its Gross Profit was $501557.0 in Q3 2025, compared to $585832.0 in Q2 2025 and $943894.0 in Q1 2025.